跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NOUMED IRBESARTAN/HCT 150/12.5 irbesartan 150mg / hydrochlorothiazide 12.5mg film coated tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
NOUMED IRBESARTAN/HCT 150/12.5 irbesartan 150mg / hydrochlorothiazide 12.5mg film coated tablet blister pack
Approved
STANDARD
NOUMED IRBESARTAN/HCT 150/12.5 irbesartan 150mg / hydrochlorothiazide 12.5mg film coated tablet blister pack
Avallon Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
ec40ba8596259f5a
Company
Avallon Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
ec40ba8596259f5a
Product Name
NOUMED IRBESARTAN/HCT 150/12.5 irbesartan 150mg / hydrochlorothiazide 12.5mg film coated tablet blister pack
Artg Id
297806
Artg Name
NOUMED IRBESARTAN/HCT 150/12.5 irbesartan 150mg / hydrochlorothiazide 12.5mg film coated tablet blister pack
Sponsor
Avallon Pharmaceuticals Pty Ltd
Company Detail Path
/organization/avallon-pharmaceuticals-pty-limited
Artg Date
2018-02-28
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
ec40ba8596259f5a
Type
Standard
Back to TGA Approvals